Abstract
The present invention relates to humanized antibodies that specifically bind to human BTN3A and their use in treating cancer and infectious disorders.
Full Text
What is claimed is:
The present invention relates to humanized antibodies that specifically bind to human BTN3A and their use in treating cancer and infectious disorders.
Timeline
Filed
05/01/2026Published
08/20/2026Granted
Not AvailableIPC Codes(8)
C07K 16/28:against receptors, cell surface antigens or cell surface determinants
A61K 9/19:lyophilised
A61K 38/20:Interleukins